-
Diphtheria is caused by Corynebacterium
diphtheriae, which is an aerobic,
gram-positive rod.
-
C.diptheria infects
mucous membranes, usually in the respiratory
tract, and open skin lesions.
-
Some strains elaborate diphtheria
toxin which causes myocarditis polyneuritis and
other systemic toxicities.
-
Primary respiratory tract
infection is manifest as tonsillopharyneal but
may involve laryngeal, nasal and thraceobronchial
structures.
-
Complications of infection include
obstruction of the respiratory tract (dyspnea,
tachypnea, cyanosis) resulting from extensive
pseudomembrane formation and swelling early in
the disease and pseudomembrane sloughing later in
disease progression.
-
Myocarditis and polyneuritits are
the most significant toxic manifestions.
-
Myocarditis occurs in about 25% of patients.
-
Polyneuritis, in mild disease, is seen about 10%
of the time; in severe disease: about 75% of the
time.
-
Treatment involves the administration
of horse-derived diptheria antitoxin.
-
Antibody therapy allows rapid
neutralization of diphtheria toxin.
-
Elimination of
C.diptheria accomplished
by antibiotic treatment using erythromycin, penicillin
G, rifampin, or clindamycin.
Holmes, R.K., Diphtheria, Other
Corynebacterial Infections and Anthrax,In Harrison's
Principles of Internal Medicine 14th edition,
(Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin,
J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc
(Health Professions Division), 1998, p. 892-895.
|